Where do Jazz Pharmaceuticals's ratios come from?

Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Free cash flow margin	28.6%-8.6pp	30.4%-3.0pp	32.1%+3.8pp	31%+4.2pp	37.2%+10.9pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Liquidity
Current ratio	2×-1.3×	1.9×-2.6×	1.7×-2.6×	1.6×-0.7×	3.4×+1.1×
Quick ratio	1.8×-1.1×	1.7×-2.3×	1.4×-2.3×	1.4×-0.6×	3×+1.1×
Cash ratio	0.3×-1.2×	0.3×-2.0×	0.6×-1.6×	0.6×-0.3×	1.5×+0.6×
Leverage
Debt-to-equity	1.2×-0.1×	1.3×-0.2×	1.4×-0.1×	1.5×-0.1×	1.3×-0.3×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Per Share
Book value per share	$68.57+0.2%	$70.82+14.2%	$64.26-2.7%	$60.57+12.1%	$68.44+15.8%
Valuation
Market capitalization	$11.64B+54.4%	$10.33B+38.8%	$7.99B+14.1%	$6.54B-2.0%	$7.54B+0.1%
Enterprise value	$16.37B+47.7%	$15.07B+34.6%	$12.08B+10.1%	$10.77B-2.9%	$11.08B-6.5%
Price / sales	2.6×+0.8×	2.4×+0.6×	1.9×+0.2×	1.6×-0.1×	1.9×-0.1×
Price / book	2.6×+0.8×	2.4×+0.6×	2×+0.3×	1.8×0.0×	1.8×-0.2×
EV / sales	3.7×+1.0×	3.5×+0.8×	2.9×+0.2×	2.6×-0.2×	2.7×-0.4×
Free cash flow yield	10.9%-9.2pp	12.6%-5.7pp	16.7%+0.6pp	19.3%+3.7pp	20.1%+6.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Jazz Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Jazz Pharmaceuticals's ratios come from?: Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.